COMMUNIQUÉS West-GlobeNewswire

Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024

06/06/2024 - 22:05

HOLLISTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be [...]

QIAGEN to discontinue NeuMoDx integrated PCR testing system, support customers during transition period

06/06/2024 - 22:05

NeuMoDx 96 and NeuMoDx 288 Molecular Systems decision taken in light of challenging post-pandemic market development trends // Reaffirms Q2 2024 outlook, raises full-year 2024 outlook for adjusted diluted EPS to $2.14 [...]

‘Disparate-Impact’ Thinking Is Destroying Medicine, States President of the Association of American Physicians and Surgeons (AAPS)

06/06/2024 - 22:02

TUCSON, Ariz., June 06, 2024 (GLOBE NEWSWIRE) -- Any notion that medicine was immune to the culture shocks in our nation was destroyed by the intersection of the George Floyd response and COVID-era policy, writes [...]

Tevogen Bio Confirms Ongoing Efficacy of TVGN 489, Its Investigational Allogeneic Off-the-Shelf Immunotherapy, Against Dominant FLiRT Strains of SARS-CoV-2

06/06/2024 - 21:52

WARREN, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically [...]

BioSenic announces 2023 full year results

06/06/2024 - 21:05

PRESS RELEASE - REGULATED INFIRMATION BioSenic stopped the patient recruitment for its Phase 2b ALLOB trial in mid-2023. BioSenic has prepared a global restructuring plan covering the years 2024-2032 and will actively [...]

BioSenic publie ses résultats annuels 2023

06/06/2024 - 21:05

COMMUNIQUÉ DE PRESSE – INFORMATION REGLEMENTEE BioSenic a arrêté le recrutement des patients pour son essai de phase 2b ALLOB à la mi-2023. BioSenic a préparé un plan de restructuration global couvrant les années 2024- [...]

Scilex Holding Company announces the U.S. FDA has approved the sNDA for commercial manufacturing of Gloperba® which will be launched in the US in the week of June 10th 2024

06/06/2024 - 20:56

Gloperba ® is the first and only liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. Gout is a painful arthritic disorder affecting an estimated 9.2 [...]

Bad-faith Physician Peer Review May Violate False Claims Act and Other Laws, according to Journal of American Physicians and Surgeons

06/06/2024 - 20:07

TUCSON, Ariz., June 06, 2024 (GLOBE NEWSWIRE) -- Physicians targeted for career destruction through hospital sham peer review have limited means of defense , but there are ways in which they can play offense, writes [...]

Nextech Appoints Rusty Frantz as Chief Executive Officer

06/06/2024 - 20:00

Experienced Healthcare Technology Executive to Lead Next Stage of Growth TAMPA, Fla., June 06, 2024 (GLOBE NEWSWIRE) -- Nextech, a market leader of comprehensive technology solutions for specialty physician practices, [...]

Repurposed Drugs Needed for COVID-19, according to Journal of American Physicians and Surgeons

06/06/2024 - 19:45

TUCSON, Ariz., June 06, 2024 (GLOBE NEWSWIRE) -- Drug repurposing, an old concept of using already approved medications for the treatment of new conditions, emerged as one of most divisive elements of the response to [...]

New Weight Loss Drugs Pose Anesthesia Risk, according to Journal of American Physicians and Surgeons

06/06/2024 - 19:02

TUCSON, Ariz., June 06, 2024 (GLOBE NEWSWIRE) -- Patients taking new weight loss/diabetes drugs such as semaglutide (Wegovy™), and their doctors, need to be aware of the significant risk they pose for sedation or [...]

Los Angeles Students Experience Behavioral Transformation Through Mindfulness Program

06/06/2024 - 19:00

Empowering Students with Emotional Resilience and Self-awareness WBP's 10-month, Weekly, Mindfulness Curriculum Yields Remarkable Results in LA Schools LOS ANGELES, June 06, 2024 (GLOBE NEWSWIRE) -- Worthy Beyond [...]

TOMI Environmental Solutions, Inc. Announces Cost Reduction Efforts to Sustain Long Term Growth and Achieve Profitability

06/06/2024 - 18:45

Company restructures executive compensation and reduces external consulting fees Expects to reduce cash used in operations by 30% (Approximately $500,000) by end of 2024 Company to continue to invest in sales personnel [...]

CG Oncology Announces Nature Medicine Publication of Final Results from CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive NMIBC

06/06/2024 - 18:14

– Final positive CORE-001 safety and efficacy findings were published simultaneously online by Nature Medicine and featured at ASCO 2024 – – 54% complete response (CR) rate in the intention-to-treat population at 24- [...]

Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital

06/06/2024 - 18:00

Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation [...]

Ipsen - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

06/06/2024 - 18:00

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (conformément à l’article L.233-8 II du Code de commerce et à l’article 223-16 du Règlement Général de l’ [...]

Market update : FOCUS-27 transformation project financing

06/06/2024 - 17:54

Press release Paris – June 6, 2024 – EUROAPI informs that it has decided to be assisted by a mandataire ad hoc in its discussions initiated in February 2024 regarding the mid-term and long-term financing of its FOCUS-27 [...]

Information marché Financement du projet de transformation FOCUS-27

06/06/2024 - 17:54

Communiqué de presse Paris – Le 6 juin 2024 – EUROAPI informe avoir décidé de se faire accompagner par un mandataire ad hoc dans les discussions entamées en février 2024 concernant le financement à moyen et long terme [...]

ACT Foundation congratulates Quebec Minister of Education on announcement to expand AEDs to all public schools

06/06/2024 - 17:27

OTTAWA, June 06, 2024 (GLOBE NEWSWIRE) -- The Advanced Coronary Treatment (ACT) Foundation congratulates Education Minister Bernard Drainville for his announcement to ensure Automated External Defibrillators (AEDs) in [...]